CL-184005

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameCL-184005

Drug Alias NameCL-184005

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPlatelet activating factor receptor antagonists

TargetsPlatelet activating factor receptor

Therapy Area/IndicationsShock, SepticGram-Negative Bacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsShock, SepticGram-Negative Bacterial Infections

ATC CodeN/A